Proposal for Virology Research Laboratory at Nashik- India.
The coronavirus disease 2019 (covid-19) outbreak started at China in december 2019, and the disease is now a global pandemic. As a basic and guaranteed platform for the research of emerging infectious diseases, a biosafety level 3 (bsl-3) laboratory provides the hardware support for humans to recognize severe acute respiratory syndrome coronavirus 2 (sars-cov-2) and study the covid-19 prevention and treatment methods.
Laboratories play a critical role in surveillance, diagnosis and monitoring of viral disease as well as in the understanding of the genetic changes in the viral genome.
Establishment of a reliable viral laboratory is a prerequisite for a strong public health response to emerging viral diseases. Unfortunately, several developing countries lack adequate capacity to diagnose viral infections. India is also one of those countries facing acute shortage of such facilities. The design program intends to address the same issue.
